Altersbedingte Makuladegeneration
Augenheilkunde up2date · 01.08.2024 · 14 (03) · 213-228
DOI: 10.1055/a-2158-3322 ↗Kurz gefasst
Fachartikel in der Zeitschrift Augenheilkunde up2date, erschienen am 01.08.2024. Verfasst von Henrik Faatz und 1 weiteren Autor:innen. Die Arbeit nennt 25 Literaturangaben.
Abstract (Originalsprache)
Age-related macular degeneration (AMD) continues to be the most common hereditary disease among older people in the western world. In addition to the clinical examination, multimodal imaging with fluorescein angiography, optical coherence tomography, fundus autofluorescence and fundus photography are crucial for the correct diagnosis and classification. This is particularly important with regard to risk assessment for the development of a late form of the disease. Since the introduction of intravitreal therapy against vascular endothelial growth factor (VEGF), the treatment options for neovascular AMD have increased significantly and the prognosis for patients in terms of maintaining their vision has improved. The hope is to develop stronger and longer-lasting drugs and also to obtain approval for drugs to treat geographic atrophy. It is therefore of great importance to be able to make a quick and correct diagnosis for patients. In this paper we want to present an overview of the pathophysiology, classification and diagnosis of AMD.
Zitieren
APA
Faatz, H., & Lommatzsch, A. P. (2024). Altersbedingte Makuladegeneration. Augenheilkunde up2date, 14(03), 213-228. https://doi.org/10.1055/a-2158-3322
Vancouver
Faatz H, Lommatzsch AP. Altersbedingte Makuladegeneration. Augenheilkunde up2date. 2024;14(03):213-228. doi:10.1055/a-2158-3322
BibTeX
@article{Faatz2024,
author = {Faatz, Henrik and Lommatzsch, Albrecht Peter},
title = {Altersbedingte Makuladegeneration},
journal = {Augenheilkunde up2date},
year = {2024},
volume = {14},
number = {03},
pages = {213--228},
doi = {10.1055/a-2158-3322}
}
EUVIMED